$1.490
-0.010 (-0.67%)收盘时
CRIS 同业对比
In the context of the broader market, CRIS competes directly with industry leaders such as BCAB and CHGA. With a market capitalization of $4.37M, it holds a leading position in the sector. When comparing efficiency, CRIS's gross margin of N/A stands against BCAB's 100.00% and CHGA's N/A. Such benchmarking helps identify whether Curis Inc is trading at a premium or discount relative to its financial performance.
Curis Inc 财务表现
Curis reported total revenue of $2.93 million in Q3 2024, but faced a net loss of $24.2 million in Q1 2026, reflecting ongoing financial challenges. Despite this, the gross margin was exceptionally high at 104.37% in Q3 2024, indicating strong product profitability when operational issues are resolved.
Financials
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。